INNOVAX-ND
Innovax-ND delivers long-term protection without reaction in a single dose. As well as keeping birds healthy in the face of Newcastle disease and Marek’s disease, it is also the best foundation for a Protectotype™ defense against infectious bronchitis.
Advantages
Protection against multiple diseases
No vaccine reactions – improved bird performance
Convenient application – in ovo or subcutaneous
Long-lasting immunity of at least 60 weeks DOI
How It Works
When Innovax-ND is applied, it causes an immune response in the vaccinated chicken and antibodies against the F protein are produced. If the vaccinated chicken comes into contact with the actual Newcastle disease (ND) virus, these antibodies bind to the F proteins on its surface and stop the virus from attaching itself to the cells to prevent infection. Innovax-ND also results in an immune response against the Marek’s disease virus. Find out more in our Mode Of Action video.
Long-Term Protection Without Reaction
Innovax-ND is a key component in preventing Newcastle disease (ND), providing long-term protection without the costly reactions of conventional live ND vaccines. Innovax-ND can be administered with one dose in the hatchery – either in ovo to 18-day chicken embryos or by subcutaneous injection of chicks at one day of age – and can be easily combined with other respiratory vaccine programs.
Breakthrough Innovation
Innovax-ND is a breakthrough in Newcastle disease control. This vaccine initiates immunity development during the bird’s first four weeks of life with minimal impact on its metabolism. Removing any significant metabolic reaction during the first several weeks of life while birds are growing and developing immunity has a positive effect on flock growth rates.
Easy-to-Administer
Effective protection begins at the hatchery with either in ovo or subcutaneous application. As a replacement for Marek’s only vaccination, Innovax-ND does not change any hatchery vaccination processes.
Convenient to use, Innovax-ND can be administered in a single dose in the hatchery either in ovo or by subcutaneous injection of chicks at one day of age and can be easily combined with other respiratory vaccine programs.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global